SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 27, 2004
ALLERGAN, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 1-10269 | 95-1622442 | ||
| (State or Other Jurisdiction | (Commission File Number) | (IRS Employer | ||
| of Incorporation) | Identification Number) |
| 2525 Dupont Drive | 92612 | |
| Irvine, California | (Zip Code) | |
| (Address of principal executive offices) |
(714) 246-4500
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
| Item 5. Other Events. | ||||||||
| Item 7. Exhibits. | ||||||||
| SIGNATURES | ||||||||
| Exhibit Index | ||||||||
| EXHIBIT 99.1 | ||||||||
| EXHIBIT 99.2 | ||||||||
Item 5. Other Events.
Allergan announced today that Trevor M. Jones, Ph.D. has been appointed to its Board of Directors, effective July 27, 2004. Professor Jones will serve as a member of Allergan’s Corporate Governance and Science and Technology Committees. Professor Jones will serve as a Class II director and his term will expire at Allergan’s Annual Meeting of Stockholders in 2006.
Allergan also announced today that Scott M. Whitcup, M.D. has been elected to the position of Executive Vice President, Research & Development.
The full text of the press releases relating to Professor Jones’ appointment and Dr. Whitcup’s election are filed as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by this reference.
Item 7. Exhibits.
99.1
|
Press Release dated July 28, 2004 announcing the appointment of Trevor M. Jones, Ph.D. to the Allergan Board of Directors. | |
99.2
|
Press Release dated July 28, 2004 announcing the election of Scott M. Whitcup as Executive Vice President, Research & Development. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ALLERGAN, INC. |
|||
| Date: July 28, 2004 | By: | /s/ Douglas S. Ingram | |
| Name: | Douglas S. Ingram | ||
| Title: | Executive Vice President, General Counsel and Secretary | ||
Exhibit Index
| Exhibit |
Description of Exhibit |
|
99.1
|
Press Release dated July 28, 2004 announcing the appointment of Trevor M. Jones, Ph.D. to the Allergan Board of Directors. | |
99.2
|
Press Release dated July 28, 2004 announcing the election of Scott M. Whitcup as Executive Vice President, Research & Development. |